173 related articles for article (PubMed ID: 26640580)
21. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
22. Avian reovirus σA-modulated suppression of lactate dehydrogenase and upregulation of glutaminolysis and the mTOC1/eIF4E/HIF-1α pathway to enhance glycolysis and the TCA cycle for virus replication.
Chi PI; Huang WR; Chiu HC; Li JY; Nielsen BL; Liu HJ
Cell Microbiol; 2018 Dec; 20(12):e12946. PubMed ID: 30156372
[TBL] [Abstract][Full Text] [Related]
23. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
[TBL] [Abstract][Full Text] [Related]
24. Aglycemic HepG2 Cells Switch From Aminotransferase Glutaminolytic Pathway of Pyruvate Utilization to Complete Krebs Cycle at Hypoxia.
Ježek J; Plecitá-Hlavatá L; Ježek P
Front Endocrinol (Lausanne); 2018; 9():637. PubMed ID: 30416487
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic Characterization of LW6, a Novel Hypoxia-Inducible Factor-1α (HIF-1α) Inhibitor in Mice.
Lee JY; Lee K; Lee K; Kang JS; Kim MJ; Yoo DG; Kim JA; Shin EJ; Oh SJ
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921487
[TBL] [Abstract][Full Text] [Related]
26. Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure.
Wilkins HM; Koppel S; Carl SM; Ramanujan S; Weidling I; Michaelis ML; Michaelis EK; Swerdlow RH
J Neurochem; 2016 Apr; 137(1):76-87. PubMed ID: 26811028
[TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3‑dioxygenase downregulates T‑cell receptor complex ζ‑chain and c‑Myc, and reduces proliferation, lactate dehydrogenase levels and mitochondrial glutaminase in human T‑cells.
Eleftheriadis T; Pissas G; Antoniadi G; Tsogka K; Sounidaki M; Liakopoulos V; Stefanidis I
Mol Med Rep; 2016 Jan; 13(1):925-32. PubMed ID: 26647830
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte reaction affects glucose influx and enzymes involved in aerobic glycolysis and glutaminolysis in alloreactive T-cells.
Eleftheriadis T; Pissas G; Yiannaki E; Markala D; Arampatzis S; Antoniadi G; Liakopoulos V; Stefanidis I
Hum Immunol; 2013 Dec; 74(12):1501-9. PubMed ID: 23993986
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
Beyfuss K; Hood DA
Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
[TBL] [Abstract][Full Text] [Related]
30. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
31. LW6 enhances chemosensitivity to gemcitabine and inhibits autophagic flux in pancreatic cancer.
Zhang X; Kumstel S; Jiang K; Meng S; Gong P; Vollmar B; Zechner D
J Adv Res; 2019 Nov; 20():9-21. PubMed ID: 31193017
[TBL] [Abstract][Full Text] [Related]
32. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells.
Feron O
Radiother Oncol; 2009 Sep; 92(3):329-33. PubMed ID: 19604589
[TBL] [Abstract][Full Text] [Related]
33. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
[TBL] [Abstract][Full Text] [Related]
34. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
35. Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism.
Brand K
Biochem J; 1985 Jun; 228(2):353-61. PubMed ID: 2861809
[TBL] [Abstract][Full Text] [Related]
36. The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
Mai L; Luo M; Wu JJ; Yang JH; Hong LY
Neoplasma; 2019 Sep; 66(5):776-784. PubMed ID: 31169018
[TBL] [Abstract][Full Text] [Related]
37. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance.
Newsholme EA; Crabtree B; Ardawi MS
Q J Exp Physiol; 1985 Oct; 70(4):473-89. PubMed ID: 3909197
[TBL] [Abstract][Full Text] [Related]
38. Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells.
Kim MH; Kim H
J Cancer Prev; 2013 Sep; 18(3):221-6. PubMed ID: 25337549
[TBL] [Abstract][Full Text] [Related]
39. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
40. Mammalian target of differentiation-inducing factor-1 is mitochondrial malate dehydrogenase for activation of AMP-activated protein kinase and induction of mitochondrial fission.
Arioka M; Miura K; Han R; Igawa K; Takahashi-Yanaga F; Sasaguri T
Life Sci; 2024 Jun; 351():122807. PubMed ID: 38852800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
